- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02694692
Trial of Repeated Analgesia With Kangaroo Care - 18 Month Follow-up (TRAKC18)
Study Overview
Status
Conditions
Detailed Description
Background: Infants in the Neonatal Intensive Care Unit receive an average of 7 painful procedures daily yet less than half receive interventions to manage pain. Importantly, there are adverse long-term effects associated with untreated pain. Moreover, the developmental trajectory of an infant born preterm is further compromised by prolonged periods of separation from their mothers during their hospital stay that also impacts mother-infant relationships. Thus, there is a crucial need to minimize procedural pain and associated consequences. Kangaroo Care (KC) is an effective strategy for reducing procedural pain and promoting mother-infant interactions in infants demonstrated in multiple clinical trials and systematic reviews. Not known is the impact of consistent KC for pain on long term outcomes. The primary aim for this study is to determine if maternal KC provided during painful procedures in early life will mitigate stress release and will improve neurobehavioural outcomes in infants, decrease subsequent pain response, and enhance maternal-child interaction beyond the period of hospitalization.
Research Design: Using a randomized clinical trial follow up design, mother-infant dyads taking part in the current CIHR and NSHRF-funded TRAKC trial (randomized to one of three interventions during all routine clinically necessary painful procedures for the duration of their initial neonatal intensive care unit hospital stay (KC/placebo; sucrose alone, considered to be standard care; or KC/ sucrose) will be compared on neurobehavioural outcomes up to 18 months.
Procedure: Eligible mother-infant dyads will be contacted prior to routine 2, 6, 12 and 18 month clinic visits where during these visits, infants will undergo an immunization and naturalistic observations will be recorded. Coders blinded to the study will score pain intensity and maternal comforting behavior using validated measures. At the 18 month visit, trained medical assessors blind to group assignment will perform the primary outcome measure, Bayley Scales of Infant Development (3rd ed) (BSID-III).
Outcomes: The investigators hypothesize that infants from the current TRAKC trial who were assigned to either KC group (alone or in combination with sucrose) when compared to those infants in the sucrose alone group will have: Primary outcome: H1. higher scores on the BSID-III at 18 months corrected postnatal age. Secondary outcomes: H2. higher scores in socio-affective development (Social-Emotional axis of the BSID-III and the Brief Infant Toddler Social Emotional Assessment (BITSEA); H3. lower scores on Negative Affectivity, higher scores on Surgency/Extraversion and Effortful Control as measured by the Early Childhood Behavior Questionnaire (ECBQ); H4. lower pain scores measured using the Modified Behavioral Pain Scale (MBPS) at 2, 6, 12, and 18 month;. H5. higher maternal infant interaction scores measured using Measure of Adult and Infant Soothing and Distress Scale (MAISD) at 2, 6, 12 and 18 months.
Sample size: The sample size is 159 mother-infant dyads at 18 months.
Benefits of the Research Project: New evidence about the long-term impact of early KC provided during early painful procedures is important to the effective management of procedural pain and development in vulnerable infants. By fully integrating mothers and families as active participants, it will have direct implications regarding the improvement of outcomes of at-risk newborns, not only for their immediate physiological stability and later development, but also their families, and the health care system in general.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Marsha Campbell-Yeo, RN, NNP, PhD
- Phone Number: 902-470-7455
- Email: marsha.campbellyeo@iwk.nshealth.ca
Study Contact Backup
- Name: Justine Dol, MSc
- Phone Number: 902-470-6769
- Email: justine.dol@iwk.nshealth.ca
Study Locations
-
-
Nova Scotia
-
Halifax, Nova Scotia, Canada, B3K6R8
- Recruiting
- IWK Health Centre
-
Contact:
- Marsha Campbell-Yeo, RN, NNP, PhD
- Phone Number: 902-470-7455
- Email: marsha.campbellyeo@iwk.nshealth.ca
-
Contact:
- Justine Dol, MSc
- Phone Number: 902-470-6769
- Email: justine.dol@iwk.nshealth.ca
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Participation in the original TRAKC trial (Born less than 36 6/7 weeks gestational age and were stable enough to be held in KC)
- Participants live within 100 km from hospital or are willing to routinely return to the IWK for follow-up
Exclusion criteria from the initial TRAKC trial included major congenital anomalies, receiving narcotics, or surgery.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Follow-up
No further interventions are planned for this trial and the three pain management interventions from the original study (NCT01561457) will remain our comparison groups (Kangaroo Mother Care alone, Sucrose alone, and Kangaroo Mother Care & Sucrose).
All participants will be invited to back to the IWK Health Centre to receive their Vaccinations at 2, 6, 12 and 18 month time points as well as for their Neurodevelopment assessment at 18 corrected age (BSID-III).
|
Participants will be invited back to IWK Health Centre at time points that correspond to their 2, 6, 12 and 18 month vaccinations and will receive their vaccinations according to Nova Scotia schedule.
During the 18 month follow-up visit, the infants will also undergo neurodevelopmental assessment.
Trained medical assessors also blind to original study group assignment will examine the child using the BSID-III Cognitive and Motor Sections.
Participants will also be contacted at the infants 18 month corrected postnatal age for the BSIDIII.
Parents will be asked to complete the Early Childhood Behaviour Questionnaire and the Brief Infant Toddler Social Emotional Assessment.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Bayley Scales of Infant Development (BSID-III)
Time Frame: 18 months corrected postnatal age
|
The Bayley Scales of Infant and Toddler Development (3rd edition; BSID-III) , the most widely used standardized assessment of early milestone-based development in young children, evaluates five domains related to development of infants from 1 to 42 months of age: cognitive, language, motor, adaptive behaviour, and social-emotional.
|
18 months corrected postnatal age
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Brief Infant Toddler Social Emotional Assessment (BITSEA)
Time Frame: 18 month corrected postnatal age
|
The BITSEA is the Brief form of the Infant Toddler Social and Emotional Assessment, which covers domains of behaviour.
The BITSEA is effective for children aged 12 to 36 months.
|
18 month corrected postnatal age
|
Early Childhood Behaviour Questionnaire (ECBQ)
Time Frame: 18 month corrected postnatal age
|
The ECBQ was developed and validated to measure temperament in toddlers between 18 and 36 months of age and has shown adequate levels of reliability and validity.
The 201-item parent-report questionnaire assesses 18 dimensions of temperament.
|
18 month corrected postnatal age
|
Modified Behavioral Pain Scale (MBPS)
Time Frame: 2, 6, 12, and 18 months
|
The MBPS, a well-validated acute pain scale used to measure procedural pain, including needle related pain in infant populations, starting at 2 months.
The MBPS assesses pain in terms of three observable behaviours: facial expressions, cry, and body movement.
|
2, 6, 12, and 18 months
|
Measure of Adult and Infant Soothing and Distress Scale (MAISD)
Time Frame: 2, 6, 12, and 18 months
|
This is a behavioural measure developed to assess adult and infant behaviour during medical procedures.
|
2, 6, 12, and 18 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Marsha Campbell-Yeo, RN, NNP, PhD, IWK Health Centre
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 1017737
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pain
-
University Hospital Schleswig-HolsteinZealand University Hospital; European Regional Development Fund; Design School...CompletedPain, Acute | Pain, Chronic | Pain Measurement | Pain, CancerGermany
-
Flowonix MedicalApproved for marketingBack Pain | Leg Pain | Trunk Pain | Intractable Pain | Arm Pain
-
Dow University of Health SciencesRecruitingLow Back Pain | Chronic Low-back Pain | Low Back Pain, Mechanical | Mechanical Low Back Pain | Pain, Chronic | Pain, Back | Lower Back Pain Chronic | CLBP - Chronic Low Back PainPakistan
-
Dr. Negrin University HospitalCompletedPostoperative Pain, Acute | Postoperative Pain, ChronicSpain
-
George Washington UniversityRecruitingCervical Fusion | Pain, Back | Pain, Neck | Myofacial PainUnited States
-
Universitat Jaume ICompletedPain, Acute | Pain, Chronic | OncologySpain
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Postoperative Pain, Acute | Postoperative Pain, Chronic | VATSTurkey
-
Janssen Research & Development, LLCCompletedPain, Radiating | Pain, Burning | Pain, Crushing | Pain, Migratory | Pain, SplittingUnited States, France, Spain, Poland, Portugal
-
susanne beckerSNSFCompletedLow Back Pain | Pain, Acute | Pain, ChronicSwitzerland
-
University of Campinas, BrazilCompletedPREGNANCY | LUMBAR BACK PAIN | PELVIC PAIN
Clinical Trials on Vaccinations at 2, 6, 12 and 18 month
-
Poitiers University HospitalCompleted
-
Institut Paoli-CalmettesRecruiting
-
Sun Yat-sen UniversityUnknown
-
Laboratoires VivacyCompleted
-
Abramson Cancer Center of the University of PennsylvaniaCompletedCandidates for BRCA 1/2 Genetic TestingUnited States
-
Hamad Medical CorporationRecruitingDiabetes | Pre-diabetesQatar
-
Norfolk and Norwich University Hospitals NHS Foundation...University of East AngliaCompleted
-
Memorial Sloan Kettering Cancer CenterCompletedHistory of CancerUnited States
-
Memorial Sloan Kettering Cancer CenterWeill Medical College of Cornell University; McMaster UniversityCompleted
-
Wake Forest University Health SciencesNational Institute on Aging (NIA)CompletedObesity | Fractures, Bone | Weight Loss | Diet Modification | Aging | Dietary Habits | Bone Loss | Weight Change, Body | Osteopenia, OsteoporosisUnited States